Fig. 3
Progression-free survival according to presence/absence of refractory disease at baseline and best response achieved to anti-PD-1 therapy. CR complete remission, PFS progression-free survival, PR partial remission
Fig. 3 | Signal Transduction and Targeted Therapy
